Fortrea Holdings Inc. (FTRE) Stock Analysis

Fortrea Holdings Inc. (FTRE) is a publicly traded company in the HEALTHCARE sector. It trades at $15.36, carries a market capitalization of $1.49B. This page summarizes the public market data, fundamentals, and frequently asked questions for FTRE, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $15.36
• Market Cap: $1.49B
• EPS: $-4.81
• 52-Week High: $18.67
• 52-Week Low: $4.36

About Fortrea Holdings Inc.

Fortrea Holdings Inc. is a prominent provider of integrated clinical development and patient access solutions for the life sciences industry, headquartered in Durham, North Carolina. The company utilizes cutting-edge methodologies and technologies to streamline clinical trials, optimize patient engagement, and deliver high-quality support throughout the drug development process. Fortrea's relentless focus on innovation and its deep expertise in navigating regulatory and market challenges make...

GNG Research Analysis

GNG Research scores Fortrea Holdings Inc. (FTRE) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for FTRE.

Frequently Asked Questions

Does FTRE pay dividends?

Fortrea Holdings Inc. (FTRE) does not currently pay a regular dividend.

What is FTRE's market cap?

Fortrea Holdings Inc. (FTRE) has a market capitalization of $1.49B with a current stock price of $15.36.